Your trusted source for investing success

Tag: tetrahydrocannabinol

Ready to invest in Cannabis? Get your guide today.

Click below to get an INN Insider's Report on marijuana investing (value of $49) for FREE. Limited time offer. No credit card required.

Give me my free guide!
Satipharm Commences Sale of Medicinal Cannabis Capsules to Australian Patients

Satipharm Commences Sale of Medicinal Cannabis Capsules to Australian Patients

Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company”) through its wholly owned Swiss subsidiary, Satipharm AG (“Satipharm”), is pleased to advise that it’s Melbourne-based distribution partner, HL Pharma Pty Ltd (“HL Pharma”), has commenced distribution of Satipharm’s Gelpell-CBD™ capsules to approved patients in Australia.

Harvest One provides Update on subsidiary Satipharm and Sales License

Harvest One provides Update on subsidiary Satipharm and Sales License

Harvest One Cannabis Inc.(TSXV:HVST)  is pleased to provide a market update on its wholly owned subsidiary, Satipharm AG (“Satipharm”):

Satipharm has received German “Free Sales Certificate” reducing constraints for international export
Australian Regulatory Authority has issued final approval for CBD capsule prescription in Australia
Strong increase in European dietary supplement

ABcann Releases High Level CBD Product and Launches Initial Oils Strategy

ABcann Releases High Level CBD Product and Launches Initial Oils Strategy

ABcann Global Corporation (TSXV:ABCN) is pleased to announce the release of one of Canada’s highest legal CBD:THC (cannabidol:tetrahydrocannabinol) ratio products available on the market by its wholly-owned subsidiary, ABcann Medicinals Inc.
The release of CBD-Med is part of the Company’s strategy to provide a diverse range of products as it formally initiates

Lexaria Bioscience Corp. Engages NetworkNewsWire for Corporate Communications Solutions

Lexaria Bioscience Corp. Engages NetworkNewsWire for Corporate Communications Solutions

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP), an innovative company licensing proprietary technology for delivery of bioactive compounds including cannabinoids, announces that it has engaged the corporate communications expertise of NetworkNewsWire (“NNW”).

“We are excited to be on the cutting-edge of bioscience, developing better ways to deliver health-enhancing cannabinoids to the body,” says Lexaria Bioscience CEO and

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Cannabis Weekly Round-Up: Quebec Reveals Marijuana Bill

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/cannabis-weekly-roundup/